We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

All-in-One Test Provides Faster Testing for Persistent Diarrhea

By LabMedica International staff writers
Posted on 18 Apr 2017
Print article
Image: The IBcause kit comes with everything needed for private stool sample collection (Photo courtesy of Prometheus Laboratories).
Image: The IBcause kit comes with everything needed for private stool sample collection (Photo courtesy of Prometheus Laboratories).
A convenient new multiplex diagnostic assay evaluates a unique combination of 20 stool and blood serum measures all at once, assisting healthcare providers to more rapidly test for many common causes of persistent diarrhea, compared to sequential testing with standard workup for persistent diarrhea.

Current methods of identifying the underlying cause(s) of persistent diarrhea can be slow, time-consuming, and frustrating. To help more quickly and effectively diagnose the cause(s) of a patient’s ongoing diarrhea (which may be referred to as persistent or chronic), Prometheus Laboratories (San Diego, CA, USA), of Nestlé Health Science (Epalinges, Switzerland), has launch their new assay “IBcause.”

"IBcause may help healthcare providers get to a diagnosis faster and a specific treatment plan sooner than sequential testing and empiric treatment for persistent diarrhea," said Warren Cresswell, Prometheus Diagnostics (Dx), "IBcause brings many key stool and serum assays together, including a proprietary assay that is not available elsewhere in the United States to test for bile acid malabsorption (BAM). BAM may affect up to 50% of patients with unexplained persistent diarrhea and is often overlooked or misdiagnosed as diarrhea-predominant irritable bowel syndrome (IBS-D)."

As part of patient support, new resources have been developed, including a guide, videos, a website, and telephone support to address patient questions. A convenient online portal, PrometheusOnline.com, for obtaining fast test results and information for patients, as well as test ordering and results for healthcare providers, is also available.

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS

Print article

Channels

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Analyzer 2.0 with remote test results access enhances collaboration across the healthcare system (Photo courtesy of QIAGEN)

Upgraded Syndromic Testing Analyzer Enables Remote Test Results Access

QIAGEN (Venlo, the Netherlands) has released the QIAstat-Dx Analyzer 2.0, including the Software 1.6 upgrade. This represents a significant advancement from the initial QIAstat-Dx Analyzer 1.... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The RedDrop One blood collection device has received 510(k) clearance from the U.S. FDA for prescription use (Photo courtesy of RedDrop Dx)

Innovative Blood Collection Device Overcomes Common Obstacles Related to Phlebotomy

The discomfort associated with traditional blood draws leads to a significant issue: approximately 30% of diagnostic tests prescribed by physicians are never completed by patients. This avoidance is often... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.